Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.
Часто задаваемые вопросы
В каком секторе работает Abcam plc (ABCZF)?
Abcam plc относится к сектору Здравоохранение.
Какова текущая цена акций Abcam plc (ABCZF)?
По последним данным, цена акций Abcam plc составляет 22,25 $, предыдущее закрытие — 22,25 $.
Какой коэффициент цена/прибыль (P/E) компании Abcam plc (ABCZF)?
Текущий коэффициент P/E компании Abcam plc составляет 2 225.
Выплачивает ли Abcam plc (ABCZF) дивиденды?
Нет, Abcam plc не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Abcam plc (ABCZF)?
У компании Abcam plc бета 0.863, что означает, что её волатильность примерно соответствует рыночной.
